| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 87391 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
203 |
zyl |
2024-11-21 |
| 87392 |
250612-06-7 DOTA多肽探针二聚体 |
94 |
wyh |
2024-11-21 |
| 87393 |
cas:1262403-90-6 七肽DOTA-VLASSAR |
106 |
zyl |
2024-11-21 |
| 87394 |
DOTA-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
104 |
wyh |
2024-11-21 |
| 87395 |
DOTA-NOC ；619300-53-7 |
111 |
wyh |
2024-11-21 |
| 87396 |
DOTA-奥曲肽,DOTA-Octreotide |
161 |
zyl |
2024-11-21 |
| 87397 |
DOTA-PEG5-amine ；DOTA-PEG5-NH2 |
101 |
wyh |
2024-11-21 |
| 87398 |
DOTA修饰肽,1180007-00-4,二肽Z-GGRDOTA |
100 |
zyl |
2024-11-21 |
| 87399 |
DOTA-PEG5-amine ；DOTA-PEG5-NH2 |
100 |
wyh |
2024-11-21 |
| 87400 |
DOTA-RGD,DOTA-cRGDfK |
158 |
zyl |
2024-11-21 |
| 87401 |
DOTA-Lys-Cys-Acid 二肽DOTA-Lys-Cys |
123 |
wyh |
2024-11-21 |
| 87402 |
DOTA-Ala-Ala-COOH ；DOTA-丙氨酸-丙氨酸-羧酸 |
137 |
wyh |
2024-11-21 |
| 87403 |
cas:1293368-74-7,DOTA标记的多肽 |
147 |
zyl |
2024-11-21 |
| 87404 |
Azido-mono-amide-DOTA ；1227407-76-2 |
86 |
wyh |
2024-11-21 |
| 87405 |
Gd-DOTA-HCBP-1(多肽核磁共振成像(MRI)探针) |
123 |
zyl |
2024-11-21 |
| 87406 |
DOTA octreotide,大环配体奥曲肽 |
157 |
zyl |
2024-11-21 |
| 87407 |
DOTA-(D-Gln)3-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2，DOTA修饰多肽 |
91 |
zyl |
2024-11-21 |
| 87408 |
二聚体多肽 cas:250612-06-7 dota-glu[cyclo(arg-gly-asp-d-phe-lys)]2 |
137 |
zyl |
2024-11-21 |
| 87409 |
DBCO-SS-PEG-DOTA 二苯并环辛炔-聚乙二醇之四氮杂环十二烷 |
115 |
zyl |
2024-11-21 |
| 87410 |
(R)-C3-TUNAPHOS，cas:301847-89-2， R -( - )-1,13 -双(二苯基膦)-7,8 -二氢的6H -二苯H |
149 |
zcy |
2024-11-21 |
| 87411 |
Br-C3-methyl ester，cas:4897-84-1，4-溴丁酸甲酯 |
134 |
zcy |
2024-11-21 |
| 87412 |
DOTA-(COOt-Bu)3-C4-NH2，1402393-59-2，烷基链化合物或碳链化合物 |
135 |
zcy |
2024-11-21 |
| 87413 |
Gal-C4-Chol，cas:219850-70-1，糖基化胆固醇衍生物 |
164 |
zcy |
2024-11-21 |
| 87414 |
DOTAGA-DTyr(3I)-DPhe-DLys(Sub-Lys-urea-Glu) |
104 |
zyl |
2024-11-21 |
| 87415 |
Boc-C1-PEG2-C4-Cl，cas:1835705-53-7，烷基链化合物或碳链化合物 |
99 |
zcy |
2024-11-21 |
| 87416 |
AP-C6，cas:2234276-60-7， 烷基链化合物或碳链化合物 |
151 |
zcy |
2024-11-21 |
| 87417 |
cas:467456-19-5，6-(N-6-羟基己基)酰胺荧光素， 6-FAM-C6-OH |
237 |
zcy |
2024-11-21 |
| 87418 |
1262403-91-7 ；七肽DOTA-YLYEIAR |
143 |
wyh |
2024-11-21 |
| 87419 |
cas:1261350-60-0，NH2-PEG3-C6-Cl，烷基链化合物或碳链化合物 |
137 |
zcy |
2024-11-21 |
| 87420 |
...RGD,[18F]FB-c(RGDyK),N-4-[18F]Fluorobenzoyl-c(RGDyK... |
129 |
wyh |
2024-11-21 |
| 87421 |
C6 Urea Ceramide，cas:486991-52-0，D-赤型-N-[2-(1,3-二羟基-4E-十八碳烯)]-N'-己烷-脲-鞘氨醇 |
97 |
zcy |
2024-11-21 |
| 87422 |
1262403-90-6 ；七肽DOTA-VLASSAR |
135 |
wyh |
2024-11-21 |
| 87423 |
SPDP-C6-NHS ester，cas:158913-22-5，琥珀酰亚胺基-6-[3-(2-吡啶基二硫基)丙酰胺基]己酸 |
193 |
zcy |
2024-11-21 |
| 87424 |
海藻酸钠-聚乙二醇-大环配体 ；alginate-PEG-DOTAM |
126 |
wyh |
2024-11-21 |
| 87425 |
C6 D-threo Ceramide (d18:1/6:0)，cas:189894-79-9，鞘氨醇衍生物 |
190 |
zcy |
2024-11-21 |
| 87426 |
DOTA-(COOt-Bu)3-azide，1402795-92-9 |
102 |
wyh |
2024-11-21 |
| 87427 |
cas:1957235-98-1；Thalidomide-NH-C6-NH2 hydrochloride；沙利度胺衍生物 |
110 |
zcy |
2024-11-21 |
| 87428 |
DOTA-cyclo(Arg-Gly-Asp-DPhe-Lys) |
125 |
wyh |
2024-11-21 |
| 87429 |
DOTA-TMTP1的结构与组成 |
152 |
wyh |
2024-11-21 |
| 87430 |
DOTA-MeTz，1610950-41-8，DOTA-甲基四嗪 |
104 |
zyl |
2024-11-21 |
| 87431 |
DOTA-c(RGDfK)的结构特点 |
118 |
wyh |
2024-11-21 |
| 87432 |
C6 NBD Ceramide，N-[6-[(7-硝基-2-1,3-苯并恶二唑-4-基)氨基]己酰基] -D-赤型-鞘氨醇 |
270 |
zcy |
2024-11-21 |
| 87433 |
DOTA-「Tyr3」-Octreotide ；204318-14-9 |
112 |
wyh |
2024-11-21 |
| 87434 |
cas:619300-53-7 DOTA NOC acetate |
111 |
zyl |
2024-11-21 |
| 87435 |
p-SCN-Bn-DOTA ；127985-74-4 |
106 |
wyh |
2024-11-21 |
齐岳微信公众号
官方微信
库存查询